Antibodies and/or conjugates thereof which bind to the amino terminal fragment of urokinase, compositions and uses thereof

Details for Australian Patent Application No. 2004290585 (hide)

Owner Attenuon LLC

Inventors Gawlak, Susan; Mazar, Andrew P; Parry, Graham; Gladstone, Patricia L; Ternansky, Robert J

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2004290585

PCT Pub. Number WO2005/048822

Priority 60/523,255 18.11.03 US

Filing date 18 November 2004

Wipo publication date 2 June 2005

International Classifications

A61K 51/10 (2006.01) Preparations containing radioactive substances for use in therapy or testing

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 49/00 (2006.01) Preparations for testing

C07K 16/40 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against enzymes

Event Publications

15 June 2006 PCT application entered the National Phase

  PCT publication WO2005/048822 Priority application(s): WO2005/048822

1 April 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004290587-Alpha 1-antitrypsin compositions and treatment methods using such compositions

2004290583-Implantable heart valve prosthetic devices having intrinsically conductive polymers